Understanding how SPRTN protease helps repair DNA damage
Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair
This study is looking at how a protein called SPRTN helps fix problems in our DNA that can lead to serious health issues, like Ruijs-Aalfs syndrome, and aims to find ways to improve DNA repair to help people with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11059227 on NIH RePORTER |
What this research studies
This research investigates the role of SPRTN protease in repairing DNA-Protein crosslinks, which can cause serious issues like genome instability and cell death if not properly addressed. By studying how SPRTN functions and its regulation, the research aims to uncover mechanisms that could improve DNA repair processes. This could lead to better understanding and treatment strategies for conditions like Ruijs-Aalfs syndrome, which is associated with mutations in the SPRTN gene. The approach includes characterizing novel regulators of SPRTN and exploring how they affect DNA repair pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with Ruijs-Aalfs syndrome or those with genetic predispositions to conditions involving DNA repair deficiencies.
Not a fit: Patients without genetic mutations affecting DNA repair mechanisms or those not diagnosed with related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients with genome instability and enhance the effectiveness of cancer therapies.
How similar studies have performed: Previous research has shown promise in understanding DNA repair mechanisms, but this specific focus on SPRTN protease regulation is relatively novel.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Ghosal, Gargi — University of Nebraska Medical Center
- Study coordinator: Ghosal, Gargi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.